{
    "2018-08-23": [
        [
            {
                "time": "",
                "original_text": "白云山关于全资子公司收到药品注册批件的公告",
                "features": {
                    "keywords": [
                        "药品注册",
                        "全资子公司",
                        "白云山"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[审慎增持评级]白云山(600332)中报点评：中期业绩实现较快增长 大健康板块利润率进入上升通道",
                "features": {
                    "keywords": [
                        "中期业绩",
                        "大健康板块",
                        "利润率",
                        "上升通道"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "大健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]白云山(600332/00874.HK)中报点评：1H18主营净利润增长符合预期 2Q18扣非净利润低于预期",
                "features": {
                    "keywords": [
                        "主营净利润",
                        "扣非净利润",
                        "1H18",
                        "2Q18"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "白云山半年盈利逾100% 大商业板块增长迅猛",
                "features": {
                    "keywords": [
                        "半年盈利",
                        "大商业板块",
                        "增长迅猛"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "商业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "广药白云山净利同比增126% 巨星品种、科技创新双轮驱动",
                "features": {
                    "keywords": [
                        "净利同比增",
                        "巨星品种",
                        "科技创新",
                        "双轮驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级]白云山(600332)中报点评：王老吉盈利提升主逻辑验证 库存消化影响Q2收入",
                "features": {
                    "keywords": [
                        "王老吉",
                        "盈利提升",
                        "库存消化",
                        "Q2收入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "饮料",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "金股预测早间版：8股有望开启估值修复",
                "features": {
                    "keywords": [
                        "金股预测",
                        "估值修复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}